| Serial Number | 79237055 |
| Word Mark | GREENWICH |
| Filing Date | Tuesday, April 24, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, April 14, 2020 |
| Registration Number | 6031354 |
| Registration Date | Tuesday, April 14, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 28, 2020 |
| Goods and Services | Pharmaceutical and medical preparations and substances in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols, for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical and medical preparations with cannabinoids as active ingredient, namely, a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; pharmaceutical preparations and substances for the treatment of epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical preparations and substances for the treatment of convulsions and seizures associated with epilepsy associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; pharmaceutical and medical preparations for the treatment of symptoms associated with epilepsy including pain, muscle spasticity and spasms, bladder problems and sleep disorders associated with Dravet Syndrome and Lennox-Gestaut Syndrome in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols; medicinal oils in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of Dravet Syndrome and Lennox-Gestaut Syndrome; medicinal infusions in the nature of a drug product in finished dosage formulation that contains cannabidiol derived from cannabis and no more than 0.1 percent residual tetrahydrocannabinols for the treatment of epilepsy, convulsions and seizures associated with Dravet Syndrome and Lennox-Gestaut Syndrome |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 24, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GW Pharma Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 20 - NOT AVAILABLE |
| Address | GB |
| Party Name | GW Pharma Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 20 - NOT AVAILABLE |
| Address | GB |
| Party Name | GW Pharma Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 20 - NOT AVAILABLE |
| Address | GB |
| Event Date | Event Description |
| Saturday, November 20, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, September 15, 2021 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Wednesday, September 15, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, September 15, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, September 15, 2021 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Saturday, September 5, 2020 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Monday, August 17, 2020 | FINAL DISPOSITION NOTICE SENT TO IB |
| Monday, August 17, 2020 | FINAL DISPOSITION PROCESSED |
| Tuesday, July 14, 2020 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Tuesday, April 14, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, January 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 28, 2020 | PUBLISHED FOR OPPOSITION |
| Friday, January 24, 2020 | NOTIFICATION PROCESSED BY IB |
| Friday, January 10, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Wednesday, January 8, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, January 8, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, January 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, December 25, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 25, 2019 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, December 23, 2019 | ASSIGNED TO LIE |
| Friday, December 20, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, December 19, 2019 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, December 19, 2019 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 19, 2019 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, December 19, 2019 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, June 20, 2019 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Thursday, June 20, 2019 | FINAL REFUSAL E-MAILED |
| Thursday, June 20, 2019 | FINAL REFUSAL WRITTEN |
| Tuesday, March 19, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 18, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 18, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Sunday, October 7, 2018 | REFUSAL PROCESSED BY IB |
| Wednesday, September 19, 2018 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Tuesday, September 18, 2018 | REFUSAL PROCESSED BY MPU |
| Wednesday, September 12, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, September 11, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, September 6, 2018 | ASSIGNED TO EXAMINER |
| Thursday, August 30, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, August 29, 2018 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Monday, August 27, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, August 22, 2018 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, August 21, 2018 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 14, 2018 | ASSIGNED TO EXAMINER |
| Saturday, July 28, 2018 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, July 24, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, July 19, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |